Printer Friendly

CRH Medical Corporation reaches milestone in partnership program.

VANCOUVER, Oct. 21 /PRNewswire-FirstCall/ -- CRH Medical Corporation (CRM:TSX-V) announced today that during the past few months it has trained over 100 Gastroenterologists as part of its strategic initiative to sell the Company's patented proprietary hemorrhoid banding technology directly to physicians. The Company believes this distribution approach complements its core strategy of operating Centers for Colorectal Health where the CRH technology is administered. The Company currently operates 17 such Centers across the United States.

To achieve rapid adoption of the CRH Technology by a broad segment of the medical community, the Company developed a strategic initiative to sell the Company's patented proprietary hemorrhoid banding technology, treatment protocols, marketing and operational experience directly to physicians who see patients that may be in need of hemorrhoid treatment. By adopting the use of the CRH Technology, the physician increases practice revenues, expands the continuum of care and provides a fast, painless and permanent solution to patients. The Company's initial target for this Program is the approximately 11,000 Gastroenterologists in the U.S. who perform approximately 14 million colonoscopies each year. The Company estimates that symptomatic hemorrhoids are diagnosed in 15 - 20% of all colonoscopy patients, most of which go untreated.

Commenting on this achievement, Edward Wright CEO of CRH Medical Corporation stated, "This training milestone demonstrates the substantial demand for our technology and treatment protocol by Gastroenterologists. The Gastroenterologists and practices that have been trained are experiencing significant clinical and financial results. Although the Program is in its infancy, we are encouraged by the results and look forward to further expanding this strategy."

Dr. Steve Morris, Managing Partner of Atlanta Gastroenterology Associates stated "23 of 47 Gastroenterologists in our practice have been trained with the CRH Technology and treatment protocols. I believe the CRH Technology provides Atlanta Gastroenterology with the ability to significantly improve patient outcomes and enhance our profitability."

Dr. Harry Sarles, Finance Committee Chairman, Digestive Health Associates of Texas states, "The CRH Technology and treatment protocols enable Gastroenterologists to provide an effective hemorrhoid treatment to the significant number of patients who are either diagnosed with hemorrhoids during their colonoscopy or are referred to us complaining of hemorrhoidal pain and bleeding."

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, anal fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.

About Atlanta Gastroenterology Associates:

Established more than 20 years ago, Atlanta Gastroenterology is the largest gastroenterology practice in the southeast United States dedicated to the evaluation and treatment of both digestive and liver diseases. Today, AGA has more than 45 physicians in 15 locations conveniently located throughout the metropolitan Atlanta area and in north Georgia.

About Digestive Health Associates of Texas:

One of the largest gastroenterology physician groups in the United States. With more than 30 locations covering a 100-mile radius, providing health care services for the Dallas/Fort Worth Metroplex area.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: Dean Linden, Corporate Communications, CRH Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com. Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com/ or the SEDAR website at http://www.sedar.com/
COPYRIGHT 2008 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 2008
Words:690
Previous Article:Planet Organic Health Corp Announces Annual Sales Results.
Next Article:Big Success with the Performance Evaluation of the New 5.9 GHz Tolling Technology from Kapsch TrafficCom at the Trial Facility in Denver, Colorado.


Related Articles
CRH Medical reports first quarter 2007 results.
CRH Medical Corporation reaches important patient milestone for 2007.
CRH Medical reports preliminary year end results.
CRH Medical Corporation opens Center in San Diego California.
CRH experiences significant increase in business activity.
CRH provides Partnership Program update.
Clinical data on CRH proprietary technology to be presented at prestigious meeting.
CRH O'Regan Hemorrhoid Banding system featured on a nationally syndicated television program.
CRH Medical reports Q1 2009 results.
CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters